跳至主要内容
临床试验/ISRCTN20479861
ISRCTN20479861已完成未知

A prospective randomised controlled trial to evaluate the prevention of sudden cardiac death using Implantable Cardioverter Defibrillators in dialysis patients

eiden University Medical Centre (LUMC) (The Netherlands)0 个研究点目标入组 188 人开始时间: 2007年5月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
188

研究概览

简要总结

2008 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/18561878 protocol 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30882234 results (added 04/11/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33606179/ qualitative results (added 22/02/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36016586/ Prevalence of central venous stenosis (added 30/08/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients 55 to 80 years of age
  • 2. End Stage Renal Disease (ESRD)
  • 3. Greater than 90 days after start dialysis

排除标准

  • 1. Possible living kidney donation
  • 2. Terminal congestive heart failure according New York Heart Association (NYHA) class four at time of randomisation
  • 3. Non-arrhythmic medical condition making one-year survival unlikely
  • 4. Excessive perioperative risk for ICD implantation
  • 5. Human Immunodeficiency Virus (HIV) infection
  • 6. Patients with central venous line
  • 7. Acute Myocardial Infarction (AMI) in the last 40 days
  • 8. ICD indication according current guidelines
  • 9. Expected poor compliance with protocol

研究者

发起方
eiden University Medical Centre (LUMC) (The Netherlands)

相似试验

A prospective randomised controlled trial to... | 临床试验